Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1999 · 28 citations · 15 references
Health ProfessionsChild HealthPediatricsHealth AssessmentPulmonary Function TestingPulmonologyCystic FibrosisHealth-related Quality Of LifeHealth-related Quality Of Life MeasurementPediatric Pulmonary Function TestingPulmonary Function AssessmentAcute Exacerbation TreatmentForced Expiratory Volume AssessmentForced Vital Capacity ChangeForced Vital Capacity RatioPediatric Quality Of LifePulmonary ExacerbationsTreatment Outcome AnalysisTreatment Outcome Monitoring
We attempted to determine the responsiveness and validity of the Quality of Well-Being (QWB) scale in 20 consecutive children and adolescents with cystic fibrosis. The QWB score was determined for 6-day periods immediately before and after hospital admission, and at 6- and 12-month follow-up. With the instrument's scale of zero-1, responsiveness was indicated by significant changes in QWB score (0.09), physical (0.019), social (0.021), and symptom-problem complexes (0.04) domains, and all pulmonary function tests from before to after treatment of an acute exacerbation. Only the symptom-problem complex domain significantly changed from after treatment to 6- and 12-month follow-up. Validity was shown by significant correlations between before and after QWB scores and forced vital capacity (r=0.476), residual volume total lung capacity ratio (r=0.452), forced expiratory volume in 1 second (r=0.358), and forced expiratory flow between 25% and 75% of vital capacity (r=0.35).
15
Quality of life and pharmacoeconomics in clinical trials
Joseph L. Pater · Controlled Clinical Trials · 1996 · 2.4K citations
Standardization of Spirometry—1987 Update
American Review of Respiratory Disease · 1987 · 2.3K citations
Henry J. Fuchs, Drucy Borowitz, David Høyrup Christiansen et al. · New England Journal of Medicine · 1994 · 1.5K citations · Full text